BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/18/2019 3:14:49 AM | Browse: 841 | Download: 1345
Publication Name World Journal of Diabetes
Manuscript ID 42699
Country/Territory India
Received
2018-10-05 07:51
Peer-Review Started
2018-10-06 00:18
To Make the First Decision
2018-11-16 01:44
Return for Revision
2018-11-21 03:18
Revised
2018-12-14 18:41
Second Decision
2018-12-29 03:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2018-12-30 02:47
Articles in Press
2018-12-30 02:47
Publication Fee Transferred
Edit the Manuscript by Language Editor
2019-01-22 18:15
Typeset the Manuscript
2019-02-11 06:29
Publish the Manuscript Online
2019-02-18 03:14
ISSN 1948-9358 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Endocrinology & Metabolism
Manuscript Type Systematic Reviews
Article Title SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review
Manuscript Source Invited Manuscript
All Author List Henith Raj, Harsh Durgia, Rajan Palui, Sadishkumar Kamalanathan, Sandhiya Selvarajan, Sitanshu Sekhar Kar and Jayaprakash Sahoo
ORCID
Author(s) ORCID Number
Henith Raj http://orcid.org/0000-0002-1499-4021
Harsh Durgia http://orcid.org/0000-0002-8404-5729
Rajan Palui http://orcid.org/0000-0002-2429-3595
Sadishkumar Kamalanathan http://orcid.org/0000-0002-2371-0625
Sandhiya Selvarajan http://orcid.org/0000-0002-7948-7821
Sitanshu Sekhar Kar http://orcid.org/0000-0001-7122-523X
Jayaprakash Sahoo http://orcid.org/0000-0002-8805-143X
Funding Agency and Grant Number
Corresponding Author Jayaprakash Sahoo, MD, Associate Professor, Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Room No. 5444, the 4th Floor, Superspeciality block, Pondicherry 605006, India. jayaprakash.s@jipmer.edu.in
Key Words Alanine aminotransferase; Hepatic fat; Hepatic fibrosis; Non-alcoholic fatty liver disease; Sodium-glucose cotransporter-2 inhibitor; Type 2 diabetes mellitus
Core Tip The frequent coexistence of non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes, their adverse health consequences, and lack of adequate therapeutic options makes it necessary to search for newer alternatives. Currently, pioglitazone and vitamin E are recommended in addition to lifestyle modifications for the management of NAFLD. Animal studies have shown that sodium glucose cotransporter-2 inhibitors might be beneficial in NAFLD present in diabetes patients. The current systematic review shows that sodium glucose cotransporter-2 inhibitors improve the serum level of liver enzymes, liver fat, and liver fibrosis with additional beneficial effects on various metabolic parameters in type 2 diabetes patients with NAFLD.
Publish Date 2019-02-18 03:14
Citation Raj H, Durgia H, Palui R, Kamalanathan S, Selvarajan S, Kar SS, Sahoo J. SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review. World J Diabetes 2019; 10(2): 114-132
URL https://www.wjgnet.com/1948-9358/full/v10/i2/114.htm
DOI https://dx.doi.org/10.4239/wjd.v10.i2.114
Full Article (PDF) WJD-10-114.pdf
Full Article (Word) WJD-10-114.docx
PRISMA 2009 Checklist 42699-PRISMA 2009 checklist.pdf
Manuscript File FP6740_de16_CE1MS_edit2.docx
Answering Reviewers 42699-Answering reviewers.pdf
Audio Core Tip 42699-Audio core tip.m4a
Biostatistics Review Certificate 42699-Biostatistics statement.pdf
Conflict-of-Interest Disclosure Form 42699-Conflict-of-interest statement.pdf
Copyright License Agreement 42699-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 42699-Language certificate.pdf
Supplementary Material 42699-Supplementary-Material-revision.docx
Peer-review Report 42699-Peer-review(s).pdf
Scientific Misconduct Check 42699-Scientific misconduct check.pdf
Scientific Editor Work List 42699-Scientific editor work list.pdf